ProPhase Labs Inc. held its Annual Meeting of Stockholders on July 18, 2025. During the meeting, stockholders voted on several proposals. The election of directors was approved, with Ted Karkus, Louis Gleckel, MD, Warren Hirsch, and Carolina Abenante, ESQ. being elected to the board. The appointment of Fruci & Associates II, PLLC as the company's independent auditors for the fiscal year ending December 31, 2025, was ratified. The frequency of future advisory votes on executive compensation was set to every three years. Following the meeting, Ms. Abenante was appointed to the Audit Committee, bringing the company into compliance with Nasdaq Listing Rules.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。